Pablo Corral Highlights CRIC Study: Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in CKD
Pablo Corral, Past President of Argentine Lipid Society, has shared a post on Linkedin:
“Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease
New data from the CRIC study
In CKD patients without clinical CVD, aspirin use was associated with 38% lower MI risk and 28% lower ESRD risk — but only when Lp(a) ≥50 mg/dL.
No significant benefit was seen when Lp(a) <50 mg/dL, and bleeding risk did not increase.”
Title: Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort
Authors: Alexander C. Razavi, Jing Chen, Wei Yang, Daohang Sha, Omar Dzaye, Harpreet S. Bhatia, Sotirios Tsimikas, James P. Lash, Mayank Kansal, Hernan Rincon-Choles, Viola Vaccarino, Terry A. Jacobson, Matthew J. Budoff, Roger S. Blumenthal, Seamus P. Whelton, Laurence S. Sperling, Michael J. Blaha, Jiang H
Read the full article here.
Read more on Hemostasis Today.
-
Jul 10, 2026, 10:58Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B
-
Jul 10, 2026, 10:23Stephen Brown: Help Us Shape The Future of Hemophilia A Care
-
Jul 10, 2026, 09:57Katherine Rozycki: The Future of Haematology Through Education
-
Jul 10, 2026, 09:42Biljana Andrić: The Best Transfusion Is Often The One That Can Be Avoided
-
Jul 10, 2026, 09:27Farnaz Poorhasan: FFP is More Than Just Frozen Blood Components
-
Jul 10, 2026, 02:32Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
-
Jul 10, 2026, 02:19Anita Singla: Thalassemia Screening in Pregnancy Has a Lifelong Impact
-
Jul 10, 2026, 02:07Ruman Bashir: Immune Thrombocytopenia in Pregnancy
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation